Skip to main content
SpringerLink
Log in

Low Dose Corticosteroids in Early Rheumatoid Arthritis

Can These Drugs Slow Disease Progression?

  • Leading Article
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Summary

The role of corticosteroids in treating rheumatoid arthritis is controversial, but recourse to the available evidence of efficacy should guide patient management decisions. Earlier evidence suggested that symptomatic control could be improved for periods of 6 to 12 months, but not longer, without increasing doses to unacceptably high levels. The effect of corticosteroids on joint destruction has been unclear.

Recent findings from a controlled clinical trial show that prednisolone 7.5 mg/day can significantly retard the rate of erosive progression in patients with relatively early disease (<2 years’ duration). These results have implications for both disease management and our understanding of the pathogenesis of joint destruction in rheumatoid arthritis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Byron MA, Kirwan JR. Corticosteroids in rheumatoid arthritis: is a trial of their disease modifying’ potential feasible? Ann Rheum Dis 1986; 46: 171–3

    Article  Google Scholar 

  2. Kirwan JR, and the Arthritis and Rheumatism Council Low Dose Glucocorticoid Study Group. The effect of glucocorticoids on joint destruction in rheumatoid arthritis. N Engl J Med 1995; 333: 142–6

    Article  PubMed  CAS  Google Scholar 

  3. Hilliquin P, Menkes C-J. Evaluation and management: early and established disease. In: Klippel JH, Dieppe PA, editors. Rheumatology. London: Mosby Year-Book Europe, 1994: 3.13.1–3.13.14

    Google Scholar 

  4. Hench PS, Kendall EC, Slocumb CH, et al. Effects of a hormone of the adrenal cortex (17-hydroxy-11 dehydrocroticosterone: compound E) and of pituitary adrenocorticotrophic hormone on rheumatoid arthritis. Preliminary report. Proc Staff Meet Mayo Clin 1949; 24: 181–97

    PubMed  CAS  Google Scholar 

  5. Joint Committee of the Medical Research Council and Nuffield Foundation. A comparison of cortisone and aspirin in the treatment of early cases of rheuatoid arthritis. BMJ 1954; 29: 1223–7

    Article  Google Scholar 

  6. Empire Rheumatism Council. Multi-centre controlled trial comparing cortisone acetate and acetyl salicylic in the long term treatment of rheumatoid arthritis. Ann Rheum Dis 1955; 14: 353–67

    Article  Google Scholar 

  7. Joint Committee of the Medical Research Council and Nuffield Foundation. A comparison of prednisolone with aspirin or other analgesics in the treatment of rheumatoid arthritis. Ann Rheum Dis 1960; 19: 331–7

    Article  Google Scholar 

  8. West HF. Rheumatoid arthritis. The relevance of clinical knowledge to research activities. Abstr World Med 1967; 41: 401–17

    Google Scholar 

  9. Berntsen CA, Freyberg RH. Rheumatoid patients after five or more years of glucocorticoid treatment: a comparative analysis of 183 cases. Ann Intern Med 1961; 54: 938–53

    Google Scholar 

  10. Leibling MR, Leib E, McLaughlin K. Pulse methyl-prednisolone therapy in rheumatoid arthritis. Ann Intern Med 1981; 94: 21–6

    Google Scholar 

  11. Harris Jr ED, Emkey RD, Nicholas JE, et al. Low dose prednisolone therapy in rheumatoid arthritis. A double blind study. J Rheumatol 1983; 10: 713–21

    PubMed  Google Scholar 

  12. Million R, Poole P, Kellgren JH, et al. Long term study of management of rheumatoid arthritis. Lancet 1984; i: 812–6

    Article  Google Scholar 

  13. Hansen TM, Kryger P, Elling H, et al. Double blind placebo controlled trial of pulse treatment with methylprednisolone combined with disease modifying drugs in rheumatoid arthritis. BMJ 1990; 301: 268–70

    Article  PubMed  CAS  Google Scholar 

  14. Larsen A, Dale K, Eek M. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol 1977; 18: 481–91

    CAS  Google Scholar 

  15. Hall GM, Spector TD, Griffin AJ, et al. The effect of rheumatoid arthritis and steroid therapy on bone density in postmenopausal women. Arthr Rheum 1993; 36: 1510–6

    Article  CAS  Google Scholar 

  16. Bresnihan B, Mulherin D, FitzGerald O. Synovial pathology and articular erosions in rheumatoid arthritis. Rheumatol Eur 1995; 24 Suppl. 2: 158–60

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Rheumatology Unit, University Department of Medicine, Bristol Royal Infirmary, Bristol, BS2 8HW, England

    John R. Kirwan & Keith K. T. Lim

Authors
  1. John R. Kirwan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Keith K. T. Lim
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kirwan, J.R., Lim, K.K.T. Low Dose Corticosteroids in Early Rheumatoid Arthritis. Drugs & Aging 8, 157–161 (1996). https://doi.org/10.2165/00002512-199608030-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-199608030-00001

Keywords

Search

Navigation